Trial Profile
A Real Life Retrospective Observational Study Assessing Qualitative Effects Of Omalizumab On Concomitant IgE-Mediated Disease In A Population Of Severe GINA 5 Asthmatics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2017
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma; Atopic dermatitis; Immunological disorders; Rhinosinusitis
- Focus Therapeutic Use
- 31 Mar 2017 New trial record